55 research outputs found

    Strategies nurse educators use to integrate computer -assisted instruction into their courses to teach clinical decision-making

    Get PDF
    The strategies nurse educators\u27 use to integrate computer-assisted instruction (CAI) designed to teach clinical decision-making into their courses were investigated to determine their frequency of use and effectiveness. The Integration of CAI Questionnaire, an on-line electronic survey designed by the investigator, was used to collect data. A stratified randomly-selected group of 109 schools of nursing that was a statistically representative mix of baccalaureate (BSN), associate (AD) and diploma schools from each of six geographic regions of the United States comprised the sample.;The study questions were as follows: (1) What integration strategies have nurse educators used to integrate CAI? (2) How effective did participants perceive the strategies were for increasing student learning, decreasing course costs, students\u27 time and the teachers\u27 time? (3) What were the key features of the schools and educators that integrated CAI effectively? (4) What types of software did nurse educators use to teach clinical decision-making? (5) How effective were their peers at integrating the software and how effectively did they integrate commercially-purchased and in-house produced software?;Statistical analysis consisted of measures of central tendency, frequencies, and percentages. The Pearson r was used to determine the relationships between the frequency of use and perceptions of the effectiveness of the strategies.;The findings showed that 71% of the schools used CAI and that more AD (81%) and diploma schools (80%) used CAI than BSN (56%). In fact, AD schools and teachers used CAI more on most measures and rated their peers as more effective at integrating CAI than their BSN counterparts. Twenty-nine of the 44 strategies were frequently used and 17 were perceived to be effective. Significant correlations (p \u3c 0.01) were noted for explain CAI, explain objectives, motivate, integrate, individual mode, course exam and follow-up. Technical and instructional support were the two most frequently used and effective strategies for increasing learning and decreasing students\u27 and teachers\u27 time but not costs. BSN schools used more strategies frequently but almost no differences in AD and BSN participants\u27 perceptions of effectiveness were noted. Tutorials and drill-and-practice programs were used most and 95% of the programs were commercially-purchased

    Hemoglobin variants identified in the Uganda Sickle Surveillance Study

    Get PDF
    The Uganda Sickle Surveillance Study analyzed dried blood spots that were collected from almost 100 000 infants and young children from all 10 regions and 112 districts in the Republic of Uganda, with the primary objective of determining the prevalence of sickle cell trait and disease. An overall prevalence of 13.3% sickle cell trait and 0.7% sickle cell disease was recently reported. The isoelectric focusing electrophoresis technique coincidentally revealed numerous hemoglobin (Hb) variants (defined as an electrophoresis band that was not Hb A, Hb F, Hb S, or Hb C) with an overall country-wide prevalence of 0.5%, but with considerable geographic variability, being highest in the northwest regions and districts. To elucidate these Hb variants, the original isoelectric focusing (IEF) gels were reviewed to identify and locate the variant samples; corresponding dried blood spots were retrieved for further testing. Subsequent DNA-based investigation of 5 predominant isoelectric focusing patterns identified 2 α-globin variants (Hb Stanleyville II, Asn78Lys; Hb G-Pest, Asp74Asn), 1 ÎČ-globin variant (Hb O-Arab, Glu121Lys), and 2 fusion globin variants (Hb P-Nilotic, ÎČ31-ÎŽ50; Hb Kenya, AÎł81Leu-ÎČ86Ala). Compound heterozygotes containing an Hb variant plus Hb S were also identified, including both Hb S/O-Arab and HbS/Kenya. Regional differences in the types and prevalence of these hemoglobin variants likely reflect tribal ancestries and migration patterns. Algorithms are proposed to characterize these Hb variants, which will be helpful for emerging neonatal hemoglobinopathy screening programs that are under way in sub-Saharan Africa

    MiR-34a Represses Numbl in Murine Neural Progenitor Cells and Antagonizes Neuronal Differentiation

    Get PDF
    MicroRNA (miRNA) function is required for normal animal development, in particular in differentiation pathways from stem cell and precursor populations. In neurogenesis, it is becoming increasingly appreciated that miRNAs act at many stages to ensure proper progression. In this study we examined the role of miR-34a in neural progenitor cells (NPC) derived from murine embryonic cortex. We found that over-expression of miR-34a in NPC significantly reduced the neuron yield upon in vitro induction of differentiation. MiR-34a has several predicted targets in the Notch pathway, which operates to balance progenitor self-renewal and differentiation during cortical neurogenesis. We tested several Notch pathway players for regulation by miR-34a in undifferentiated NPC, and found that mRNA and protein levels of Numbl, a negative regulator of Notch signaling, as well as two downstream pro-neural genes usually blocked by Notch signaling, NeuroD1 and Mash1, were diminished, while Notch1 and Cbf1 transcripts were enhanced by miR-34a over-expression. Using a luciferase reporter assay, we verified the Numbl 3â€Č-UTR as a direct miR-34a target. Correspondingly, knock-down of endogenous miR-34a resulted in increased Numbl, NeuroD1 and Mash1, and reduced Notch1 transcript levels. Together these results implicate Numbl as a physiologically relevant target of miR-34a in NPC, allowing for enhanced Notch signaling and inhibition of neuronal differentiation. This work extends our understanding of miR-34a-mediated control of cell differentiation from cancer to mammalian nervous system development

    Morality in the Marketplace: Consumer Protection, Regulatory Policy, and Jewish Law

    Get PDF

    Successful Use of Bortezomib in an Adolescent with Refractory TTP

    No full text
    With increasing early and upfront use of rituximab and caplacizumab in the modern management of immune-mediated thrombotic thrombocytopenic purpura (iTTP), the risk of refractory disease is expected to decline. However, despite the use of adequate initial therapy, a small subset of patients develop a refractory disease which is difficult to manage. Bortezomib has come to be known as a safe and effective treatment option for refractory iTTP, but its use in children is limited. Here, we describe the case of an adolescent patient with refractory iTTP who had a satisfactory and sustained response to the use of bortezomib

    Knowledge insufficient: the management of haemoglobin SC disease.

    No full text
    Although haemoglobin SC (HbSC) accounts for 30% of sickle cell disease (SCD) in the United States and United Kingdom, evidence-based guidelines for genotype specific management are lacking. The unique pathology of HbSC disease is complex, characterized by erythrocyte dehydration, intracellular sickling and increased blood viscosity. The evaluation and treatment of patients with HbSC is largely inferred from studies of SCD consisting mostly of haemoglobin SS (HbSS) patients. These studies are underpowered to allow definitive conclusions about HbSC. We review the pathophysiology of HbSC disease, including known and potential differences between HbSS and HbSC, and highlight knowledge gaps in HbSC disease management. Clinical and translational research is needed to develop targeted treatments and to validate management recommendations for efficacy, safety and impact on quality of life for people with HbSC
    • 

    corecore